Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
University of Copenhagen · UNSW Sydney · +10 more institutions
Abstract
Patients with type 2 diabetes and chronic kidney disease are at high risk for kidney failure, cardiovascular events, and death. Whether treatment with semaglutide would mitigate these risks is unknown.
), at least a 50% reduction in the eGFR from baseline, or death from kidney-related or cardiovascular causes. Prespecified confirmatory secondary outcomes were tested hierarchically.
in the semaglutide group (P
Citation impact
- FWCI
- 441.92
- Percentile
- 100%
- References
- 23
Authors
11- VPVlado PerkovicCorresponding
University of Copenhagen, UNSW Sydney
- KRKatherine R. Tuttle
University of Copenhagen, Providence College, University of Washington, Inland Northwest Health Services
- PRPeter Rossing
University of Copenhagen, Steno Diabetes Centers
- KWKenneth W. Mahaffey
University of Copenhagen, Stanford Medicine, Center for Clinical Research (United States)
- JFJohannes F.E. Mann
University of Copenhagen, Friedrich-Alexander-Universität Erlangen-Nürnberg
Topics & keywords
- Semaglutide
- Type 2 diabetes
- Kidney disease
- Medicine
- Diabetes mellitus
- Internal medicine
- Endocrinology
- Good health and well-being